Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash Flows From Operating Activities
Net loss	$ (1,086,438)	$ (1,265,091)
Adjustments to reconcile net loss to net cash used in operating activities:
Noncash stock based compensation expense	174,579	439,956
Depreciation and amortization	4,276	4,276
Amortization of future compensation payable	208,335	208,333
Amortization of prepaid assets	43,124	39,303
Changes in assets and liabilities:
Accounts receivable		9,888
Other receivable	(17,004)
Other assets	(31,413)	(86,420)
Accounts payable	(23,358)	(177,989)
Accrued interest	526	60,848
Accrued expenses	81,763	(20,567)
Net cash used in operating activities	(645,610)	(787,463)
Cash Flows From Investing Activities
Purchase of equipment	(70,657)
Net cash used in investing activities	(70,657)
Cash Flows From Financing Activities
Proceeds from sale of common stock	2,258,000	1,113,000
Repayment on note payable	(513,023)	(119,569)
Proceeds from the exercise of stock options and warrants	42,000	1,750
Net cash provided by financing activities	1,786,977	995,181
Net change in cash and cash equivalents	1,070,710	207,718
Cash and cash equivalents, beginning of year	3,323,290	88,415
Cash and cash equivalents, end of year	4,394,000	296,133
Supplemental disclosure of cash flow information
Cash paid for interest	355	5,243
Cash paid for taxes
Non-cash investing and financing activities
Insurance financing for prepaid insurance	117,209
Equipment investing in accounts payable	64,107
Common stock issued for repayment of convertible notes	$ 47,499